Context
Sexual-function claims sit next to approved options and real endocrine workups; peptide marketing usually skips that comparison.
Compare PT-141 (bremelanotide), melanotan-2, oxytocin, and kisspeptin-10: from an approved drug to receptor research tools, with very different evidence situations.
Peptides compared
PT-141
A cyclic melanocortin receptor agonist with an FDA-approved bremelanotide product context for acquired, generalized HSDD in premenopausal women.
Melanotan-2
An unapproved synthetic cyclic alpha-MSH analog most often discussed around tanning, libido, appetite, and online peptide products, where the clearest evidence points to regulatory and product-quality risk rather than dependable benefit.
Oxytocin
A synthetic nonapeptide with approved Pitocin obstetric-medicine labeling and different source support around intranasal neuro-social claims.
Kisspeptin-10
A 10-amino-acid kisspeptin research peptide with small human reproductive-endocrinology physiology studies and completed ClinicalTrials.gov development records, but no approved routine-use labeling.
Sources
- 1.
FDA. Notice of Opportunity for Hearing (NOOH) Manookian, Edward 8/5/16 2016.
Accessed 2026-06-09.
FDA enforcement source describing Melanotan II as an unapproved new drug marketed as an injectable tanning product; used only for regulatory-risk and claim-boundary framing.
- 2.
Other. Don't risk using tanning products containing melanotan 2025.
Accessed 2026-06-09.
Australian TGA warning source for melanotan I/II tanning products, online promotion, unapproved-product quality risk, adverse-event concerns, and advertising restrictions.
- 3.
PubMed. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder 2021.
doi:10.1056/NEJMoa2103583 PMID:34644471 Accessed 2026-06-09.
Large placebo-controlled intranasal oxytocin autism trial used to keep neuro-social claims grounded; it does not show a wellness or social-confidence benefit.
- 4.
PubMed. Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. 2011.
doi:10.1210/jc.2011-0089 PMID:21632807 Accessed 2026-06-09.
Healthy-men physiology study identifying kisspeptin-10 as the minimal bioactive kisspeptin sequence and reporting rapid LH stimulation with increased pulse frequency in the study setting.
- 5.
doi:10.1093/humrep/dev143 PMID:26089302 Accessed 2026-06-09.
Small healthy-men physiology study reporting that kisspeptin-10 and kisspeptin-54 produced similar gonadotrophin secretion, while GnRH was more potent in that controlled comparison.